Indeed, NR3C1/Glucocorticoid Receptor and TP53 signaling pathways were revealed as linked to depressive symptoms by an sPLS analysis using the 33 patients at baseline, and the involvement of these two upregulators were confirmed in the differential gene expression analysis comparing post-surgery versus baseline in MDD patients. The gene discussed is TP53; the disease is major depressive disorder.